EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Bacteria-Derived Tryptamine Ameliorates Diet-Induced Obesity and Insulin Resistance in Mice

Jongjun Lee, Hye-Rim Jang, Dongjin Lee, Yeonmi Lee iD, Hui-Young Lee iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jongjun Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Mitochondria and Metabolic Diseases, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, Republic of Korea. Hauptthemen laut MEDLINE: Insulin Resistance, Obesity, Tryptamines, Gastrointestinal Microbiome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Gachon University, National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tryptophan is an essential amino acid that is metabolized in the intestine by gut bacteria into indole derivatives, including tryptamine. However, little is known about which bacterial tryptophan metabolites directly influence obesity. In this study, we identified tryptamine as a bacterial metabolite that significantly reduced fat mass following the intraperitoneal injection of five bacterial tryptophan end-products in a diet-induced obese mouse model. Interestingly, tryptamine, a serotonin analog, inhibited both lipogenesis and lipolysis in adipose tissue, which was further confirmed in a 3T3-L1 adipocyte cell culture study. Moreover, oral tryptamine supplementation markedly reduced fat mass and improved insulin sensitivity in a long-term, high-fat-diet, pair-feeding model. These studies demonstrate the therapeutic potential of tryptamine, a bacterial tryptophan metabolite, in ameliorating obesity and insulin resistance by directly regulating lipogenesis and lipolysis in white adipose tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceObesityTryptaminesGastrointestinal MicrobiomeAnimalsMiceDiet, High-FatLipogenesisLipolysis3T3-L1 CellsMaleMice, Inbred C57BLDisease Models, AnimalAdipose Tissue, WhiteTryptophan

Stichwörter der Autor:innen

adipose tissuegut bacterial metabolitehigh-fat dietobesitytryptamine

Substanzen

TryptaminestryptamineTryptophan

Autor:innen und Institutionen

  • Laboratory of Mitochondria and Metabolic Diseases, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, Republic of Korea.
  • Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences & Technology, Gachon University, Incheon 21999, Republic of Korea.
  • Department of Molecular Medicine, Gachon University College of Medicine, Incheon 21936, Republic of Korea.

ORCID-Profile: Yeonmi Lee, Hui-Young Lee

Förderung

  • National Research Foundation of Korea
  • Gachon University
  • National Research Foundation

Zitieren

APA

Lee, J., Jang, H. R., Lee, D., Lee, Y., & Lee, H. Y. (2025). Gut Bacteria-Derived Tryptamine Ameliorates Diet-Induced Obesity and Insulin Resistance in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031327

Vancouver

Lee J, Jang HR, Lee D, Lee Y, Lee HY. Gut Bacteria-Derived Tryptamine Ameliorates Diet-Induced Obesity and Insulin Resistance in Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031327

BibTeX
@article{Lee2025,
  author = {Lee, Jongjun and Jang, Hye-Rim and Lee, Dongjin and Lee, Yeonmi and Lee, Hui-Young},
  title = {Gut Bacteria-Derived Tryptamine Ameliorates Diet-Induced Obesity and Insulin Resistance in Mice},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031327}
}
Kostenlos starten →